Evaluation of health-related quality of life and symptoms in patients with advanced non-squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 057.

Martin Reck,Julie Brahmer,Bryan Bennett,Fiona Taylor,John R Penrod,Michael DeRosa,Homa Dastani,David R Spigel,Richard J Gralla

European Journal of Cancer（2018）

引用 67|浏览22

暂无评分

摘要

•Nivolumab provided improvements in health-related quality of life in CheckMate 057.•Docetaxel was associated with stable or worsening of quality of life.•Disease-related deterioration was delayed with nivolumab versus docetaxel.

查看译文

关键词

Carcinoma,Non-small cell lung,Lung neoplasms,Docetaxel,Surveys and questionnaires,Quality of life,Nivolumab,Antineoplastic agents

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要